1. Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS). (April 2019) Authors: Adenis, A.; Bennouna, J.; Etienne, P.L.; Bogart, E.; Francois, E.; Galais, M.P.; Ben Abdelghani, M.; Michel, P.; Metges, J.P.; Dahan, L.; Conroy, T.; Ghiringhelli, F.; Drouillard, A.; El Hajbi, F.; Samalin, E.; Hiret, S.; Delaine-Clisant, S.; Mariette, C.; Penel, N.; Piessen, G. Journal: European journal of cancer Issue: Volume 111(2019) Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0108 Impact of the Radiation Therapy Quality Assurance in the phase II/III CONCORDE trial. (May 2022) Authors: Lopez, H.; Créhange, G.; Blanc, J.; M'vondo, C.; Pereira, R.; Rio, E.; Peiffert, D.; Gnep, K.; Benezery, K.; Ronchin, P.; Noel, G.; Mineur, L.; Drouillard, A.; Rouffiac, M.; Boustani, J.; Bertaut, A.; Huguet, F. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-0336 Dose escalated chemoradiotherapy in esophageal cancer : randomized phase 2/3 CONCORDE trial. (August 2021) Authors: Crehange, G.; M'vondo, C.; Bertaut, A.; Pereira, R.; Rio, E.; Peiffert, D.; Gnep, K.; Benezery, K.; Ronchin, P.; Noel, G.; Mineur, L.; Drouillard, A.; Blanc, J.; Rouffiac, M.; Boustani, J. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗